It takes two to tango: When cells interact

February 16, 2021

The fact that cells are motile and come into contact with each other is one of biology's fundamental principles. During embryonic development, cells must communicate with their neighbors in order to find their proper place in the differentiating organism. Wound healing is another process in which direct intercellular interactions are essential. In this context, motility enables cells to migrate to the location of the lesion and regenerate lost structures. Cancer cells also make use of this property to leave their site of origin in the primary tumor, which allows them to initiate the formation of metastatic tumors in other tissues.

"In recent years, biologists and physicists who study motility have mainly focused on investigating how large collectives comprising hundreds or thousands of cells coordinate their movements," says doctoral student David Brückner. His PhD supervisor Chase Broedersz is Associate Professor of Theoretical Biophysics at Ludwig-Maximilians-Universitaet (LMU) in Munich and the Vrije Universiteit (VU) in Amsterdam. "We wanted to know how pairs of cells interact when they come into contact, and set out to analyze their behavior using the methods of statistical physics."

Caged cells

To do so, Brückner and his colleagues fabricated a microscopic 'cage', which they refer to as a 'cell collider'. The use of defined geometries is a popular strategy in studies of cell motlity, but Alexandra Fink, a PhD student in the group led by Joachim Rädler, Professor of Biophysics and the Physics of Soft Matter at LMU, has now applied it in a novel context.

"The idea was to isolate two cells, while permitting them to interact in a restricted fashion," Brückner explains. This was achieved by placing single cells in each of two compartments that were connected by a narrow channel. This geometry meant that the cells could interact by extending thin membrane projections called protrusions, inevitably leading to collisions. The cell nuclei were labeled fluorescently to enable the movements of both cells to be monitored by fluorescence microscopy, so that the positions of the two could be tracked over time. "Based on the resulting experimental data, we were able to develop a model that provides a physical description of how the cells interact," says Brückner.

Evasive action on a microscopic scale

The observations revealed that when normal cells come into contact in the cell collider, their protrusions repel each other, and are then fully retracted. "When normal cells make contact, they tend to change direction so as to avoid the obstacle," says Brückner. This response to initial contact enables the cells to keep their distance from one another. "We were surprised to find that tumor cells behave in a very different way," Brückner adds.

In almost all cases, the two cancer cells tried to get past each other. With the aid of their theoretical model, the team was able to simulate this response in detail. The analysis revealed that, when two tumor cells approach each other they do not - as one might expect - slow down. Instead, they accelerate to squeeze past one another.

"These findings suggest two interesting approaches for further investigations," says Brückner. In the next step, the LMU team plan to identify the molecular bases for the very different interactions of the two cell types. Cancer cells are known to differ from their normal counterparts with respect to the sets of proteins exposed on their surfaces. Among them, cadherins - a specific class of proteins that play a vital role in mediating cell adhesion - are of particular interest.

Whether or not cadherins alone can account for the differences observed in the study is not yet known. In addition, the authors intend to examine whether bigger cell aggregates, such as those found in tumors, display patterns of motility similar to those exhibited by pairs of cells.

Ludwig-Maximilians-Universität München

Related Cancer Cells Articles from Brightsurf:

Cancer researchers train white blood cells to attacks tumor cells
Scientists at the National Center for Tumor Diseases Dresden (NCT/UCC) and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program -- be utilized for the treatment of tumors.

New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed
Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a new way to kill some multiplying human breast cancer cells by selectively attacking the core of their cell division machinery.

Breast cancer cells use message-carrying vesicles to send oncogenic stimuli to normal cells
According to a Wistar study, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells.

Breast cancer cells turn killer immune cells into allies
Researchers at Johns Hopkins University School of Medicine have discovered that breast cancer cells can alter the function of immune cells known as Natural killer (NK) cells so that instead of killing the cancer cells, they facilitate their spread to other parts of the body.

Breast cancer cells can reprogram immune cells to assist in metastasis
Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or spread, to other areas of the body.

Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells
CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia.

Drug that keeps surface receptors on cancer cells makes them more visible to immune cells
A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses.

Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells
In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.

First phase i clinical trial of CRISPR-edited cells for cancer shows cells safe and durable
Following the first US test of CRISPR gene editing in patients with advanced cancer, researchers report these patients experienced no negative side effects and that the engineered T cells persisted in their bodies -- for months.

Zika virus' key into brain cells ID'd, leveraged to block infection and kill cancer cells
Two different UC San Diego research teams identified the same molecule -- αvβ5 integrin -- as Zika virus' key to brain cell entry.

Read More: Cancer Cells News and Cancer Cells Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to